MedPath
NMPA Approval

Talazoparib Tosylate Capsules

国药准字HJ20240122

October 29, 2024

Drug Information

甲苯磺酸他拉唑帕利胶囊

泰泽纳

胶囊剂

0.25mg (按C₁₉H₁₄F₂N₆O计)

化学药品

October 29, 2024

October 28, 2029

Company Information

Applicant Company

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Nürnberger Strasse 12 90537 Feucht Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.